.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Merck
Fuji
Federal Trade Commission
Argus Health
Citi
Novartis
Covington
Moodys
McKinsey

Generated: June 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074220

« Back to Dashboard
NDA 074220 describes CORMAX, which is a drug marketed by Hi Tech Pharma and is included in one NDA. It is available from four suppliers. Additional details are available on the CORMAX profile page.

The generic ingredient in CORMAX is clobetasol propionate. There are thirteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.

Summary for NDA: 074220

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details

Pharmacology for NDA: 074220

Suppliers and Packaging for NDA: 074220

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CORMAX
clobetasol propionate
CREAM;TOPICAL 074220 ANDA Rebel Distributors Corp 42254-153 42254-153-15 1 TUBE in 1 CARTON (42254-153-15) > 15 g in 1 TUBE
CORMAX
clobetasol propionate
CREAM;TOPICAL 074220 ANDA Rebel Distributors Corp 42254-153 42254-153-30 1 TUBE in 1 CARTON (42254-153-30) > 30 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.05%
Approval Date:May 16, 1997TE:AB1RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Julphar
Chinese Patent Office
Cantor Fitzgerald
Cerilliant
Cipla
Harvard Business School
McKesson
Citi
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot